Patient -r eported o utcomes (PROs) as personalised cancer care: report from a 2023 Australian consensus meeting (PROActive)

doi:10.1016/j.eclinm.2025.103295

Review

. 2025 Jun 23:85:103295.

doi: 10.1016/j.eclinm.2025.103295. eCollection 2025 Jul.

Patient -r eported o utcomes (PROs) as personalised cancer care: report from a 2023 Australian consensus meeting (PROActive)

Carolyn G Mazariego¹, Sandra Avery², Geoffrey P Delaney^{2

3

4}, Joanna E Fardell^{5

6

7}, Susan Hayes⁸, Darren Haywood⁹, Julia Lai-Kwon^{10

11}, Sandra Nolte¹², Joanne Pearson², Natasha A Roberts^{13

14

15}, Christina Signorelli^{5

7}, Natalie Taylor¹, Kate Webber^{16

17}, Bogda Koczwara^{18

19}

Affiliations

¹ Implementation to Impact (i2i), School of Population Health, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia.
² South Western Sydney Local Health District, NSW, Australia.
³ South-Western Sydney Clinical School, University of NSW, NSW, Australia.
⁴ Ingham Institute of Health and Medical Research, Australia.
⁵ Behavioural Sciences Unit, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, NSW, Australia.
⁶ Western Sydney Youth Cancer Service, Westmead Hospital, NSW, Australia.
⁷ Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
⁸ COSA PRO Working Group Consumer Advocate, WA, Australia.
⁹ Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Driver Avenue, Moore Park, Sydney, NSW, 2021, Australia.
¹⁰ Department of Medical Oncology, Peter MacCallum Cancer Centre, VIC, Australia.
¹¹ Centre for Health Services Research, Peter MacCallum Cancer Centre, VIC, Australia.
¹² Person-Centred Research, Eastern Health Clinical School, Monash University, VIC, Australia.
¹³ STARS Education and Research Alliance, Metro North Health, QLD, Australia.
¹⁴ University of Queensland, Brisbane, Australia.
¹⁵ Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia.
¹⁶ School of Clinical Sciences, Monash University, VIC, Australia.
¹⁷ Oncology Department, Monash Health, Clayton, VIC, Australia.
¹⁸ Flinders Medical Centre, Adelaide, SA, Australia.
¹⁹ Flinders University, Adelaide, SA, Australia.

PMID: 40620611
PMCID: PMC12226390
DOI: 10.1016/j.eclinm.2025.103295

Review

Patient -r eported o utcomes (PROs) as personalised cancer care: report from a 2023 Australian consensus meeting (PROActive)

Carolyn G Mazariego et al. EClinicalMedicine. 2025.

. 2025 Jun 23:85:103295.

doi: 10.1016/j.eclinm.2025.103295. eCollection 2025 Jul.

Authors

Affiliations

¹ Implementation to Impact (i2i), School of Population Health, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia.
² South Western Sydney Local Health District, NSW, Australia.
³ South-Western Sydney Clinical School, University of NSW, NSW, Australia.
⁴ Ingham Institute of Health and Medical Research, Australia.
⁵ Behavioural Sciences Unit, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, NSW, Australia.
⁶ Western Sydney Youth Cancer Service, Westmead Hospital, NSW, Australia.
⁷ Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
⁸ COSA PRO Working Group Consumer Advocate, WA, Australia.
⁹ Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Driver Avenue, Moore Park, Sydney, NSW, 2021, Australia.
¹⁰ Department of Medical Oncology, Peter MacCallum Cancer Centre, VIC, Australia.
¹¹ Centre for Health Services Research, Peter MacCallum Cancer Centre, VIC, Australia.
¹² Person-Centred Research, Eastern Health Clinical School, Monash University, VIC, Australia.
¹³ STARS Education and Research Alliance, Metro North Health, QLD, Australia.
¹⁴ University of Queensland, Brisbane, Australia.
¹⁵ Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia.
¹⁶ School of Clinical Sciences, Monash University, VIC, Australia.
¹⁷ Oncology Department, Monash Health, Clayton, VIC, Australia.
¹⁸ Flinders Medical Centre, Adelaide, SA, Australia.
¹⁹ Flinders University, Adelaide, SA, Australia.

PMID: 40620611
PMCID: PMC12226390
DOI: 10.1016/j.eclinm.2025.103295

Abstract

This viewpoint reports on the outcomes of the 2023 Australian interest holder meeting on the use of patient-reported outcomes (PROs) in cancer care and discusses its findings in the context of the significant national investment into the collection of PRO data in Australia. The interest holders emphasised the importance for PRO data collection to be relevant to the care of individual patients and personalised to their needs and preferences to ensure direct impact on patients' care and outcomes. They also prioritised the coordination and integration of various PRO collection efforts to improve patient outcomes and care quality.

Keywords: Cancer care; Digital health; Patient centred care; Patient-reported outcomes.

PubMed Disclaimer

Conflict of interest statement

CM received consultancy fees from Movember for contribution to the PanCancer Initiative Advisory Group. SN received consultancy fees from Movember, Mapi Research Trust and Bertelsmann Foundation. SN received grant funding from the European Organisation for Research and Treatment of Cancer (EORTC).

Figures

**Fig. 1**
**Summary of identified priority areas for Patient-reported outcomes (PROs) advocacy and implementation**.

See this image and copyright information in PMC

References

1. Girgis A., Durcinoska I., Arnold A., et al. Web-based patient-reported outcome measures for personalized treatment and care (PROMPT-Care): multicenter pragmatic nonrandomized trial. J Med Internet Res. 2020;22(10) - PMC - PubMed
1. Balitsky A.K., Rayner D., Britto J., et al. Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis. JAMA Netw Open. 2024;7(8):e2424793–e. - PMC - PubMed
1. Basch E., Deal A.M., Dueck A.C., et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–198. - PMC - PubMed
1. Basch E., Deal A.M., Kris M.G., et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. - PMC - PubMed
1. Caminiti C., Maglietta G., Diodati F., et al. The effects of patient-reported outcome screening on the survival of people with cancer: a systematic review and meta-analysis. Cancers (Basel) 2022;14(21) - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- PubMed Central
Miscellaneous
- NCI CPTAC Assay Portal

[1] Girgis A., Durcinoska I., Arnold A., et al. Web-based patient-reported outcome measures for personalized treatment and care (PROMPT-Care): multicenter pragmatic nonrandomized trial. J Med Internet Res. 2020;22(10) - PMC - PubMed

[2] Girgis A., Durcinoska I., Arnold A., et al. Web-based patient-reported outcome measures for personalized treatment and care (PROMPT-Care): multicenter pragmatic nonrandomized trial. J Med Internet Res. 2020;22(10) - PMC - PubMed

[3] Balitsky A.K., Rayner D., Britto J., et al. Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis. JAMA Netw Open. 2024;7(8):e2424793–e. - PMC - PubMed

[4] Balitsky A.K., Rayner D., Britto J., et al. Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis. JAMA Netw Open. 2024;7(8):e2424793–e. - PMC - PubMed

[5] Basch E., Deal A.M., Dueck A.C., et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–198. - PMC - PubMed

[6] Basch E., Deal A.M., Dueck A.C., et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–198. - PMC - PubMed

[7] Basch E., Deal A.M., Kris M.G., et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. - PMC - PubMed

[8] Basch E., Deal A.M., Kris M.G., et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. - PMC - PubMed

[9] Caminiti C., Maglietta G., Diodati F., et al. The effects of patient-reported outcome screening on the survival of people with cancer: a systematic review and meta-analysis. Cancers (Basel) 2022;14(21) - PMC - PubMed

[10] Caminiti C., Maglietta G., Diodati F., et al. The effects of patient-reported outcome screening on the survival of people with cancer: a systematic review and meta-analysis. Cancers (Basel) 2022;14(21) - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Patient -r eported o utcomes (PROs) as personalised cancer care: report from a 2023 Australian consensus meeting (PROActive)

Affiliations

Patient -r eported o utcomes (PROs) as personalised cancer care: report from a 2023 Australian consensus meeting (PROActive)

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous

Abstract

Conflict of interest statement

Figures

Similar articles

References

Publication types

Related information

LinkOut - more resources

Full Text Sources

Miscellaneous